But it also moved the New York Times to ask on its front page in January "Drug Approved. Is Disease Real?"
And even if the disease is real and not another self fulfilling prophesy, Big Pharma will no doubt find itself back in court with suits over fibro drugs' Zyprexa-like weight gain side effects which start early in therapy with gains of as much as seven percent that do not taper off.
Yes, thanks to a bad start in 2008 Pharma has a lot of "negatives" to overcome. But unlike the presidential candidates, its troubles won't end in eleven months. They may even get worse.